title: Evasion of interferon responses by Ebola and Marburg viruses.
abstract: The filoviruses, Ebola virus (EBOV) and Marburg virus (MARV), cause frequently lethal viral hemorrhagic fever. These infections induce potent cytokine production, yet these host responses fail to prevent systemic virus replication. Consistent with this, filoviruses have been found to encode proteins VP35 and VP24 that block host interferon (IFN)-alpha/beta production and inhibit signaling downstream of the IFN-alpha/beta and the IFN-gamma receptors, respectively. VP35, which is a component of the viral nucleocapsid complex and plays an essential role in viral RNA synthesis, acts as a pseudosubstrate for the cellular kinases IKK-epsilon and TBK-1, which phosphorylate and activate interferon regulatory factor 3 (IRF-3) and interferon regulatory factor 7 (IRF-7). VP35 also promotes SUMOylation of IRF-7, repressing IFN gene transcription. In addition, VP35 is a dsRNA-binding protein, and mutations that disrupt dsRNA binding impair VP35 IFN-antagonist activity while leaving its RNA replication functions intact. The phenotypes of recombinant EBOV bearing mutant VP35s unable to inhibit IFN-alpha/beta demonstrate that VP35 IFN-antagonist activity is critical for full virulence of these lethal pathogens. The structure of the VP35 dsRNA-binding domain, which has recently become available, is expected to provide insight into how VP35 IFN-antagonist and dsRNA-binding functions are related. The EBOV VP24 protein inhibits IFN signaling through an interaction with select host cell karyopherin-alpha proteins, preventing the nuclear import of otherwise activated STAT1. It remains to be determined to what extent VP24 may also modulate the nuclear import of other host cell factors and to what extent this may influence the outcome of infection. Notably, the Marburg virus VP24 protein does not detectably block STAT1 nuclear import, and, unlike EBOV, MARV infection inhibits STAT1 and STAT2 phosphorylation. Thus, despite their similarities, there are fundamental differences by which these deadly viruses counteract the IFN system. It will be of interest to determine how these differences influence pathogenesis.
authors.affiliation: Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029, USA. chris.basler@mssm.edu
authors.forename: Christopher F
authors.initials: CF
authors.lastname: Basler
authors.forename: Gaya K
authors.initials: GK
authors.lastname: Amarasinghe
mesh_terms: D021581:Active Transport, Cell Nucleus; D000818:Animals; D029043:Ebolavirus / Q000472:pathogenicity / Q000502:physiology*; D019142:Hemorrhagic Fever, Ebola / Q000276:immunology* / Q000635:transmission / Q000821:virology*; D006801:Humans; D050835:Interferon Regulatory Factors / Q000378:metabolism; D007372:Interferons / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D008379:Marburg Virus Disease / Q000276:immunology / Q000635:transmission / Q000821:virology; D029024:Marburgvirus / Q000472:pathogenicity / Q000502:physiology*; D015398:Signal Transduction; D014764:Viral Proteins / Q000276:immunology / Q000378:metabolism; D054334:Viral Regulatory and Accessory Proteins / Q000276:immunology / Q000378:metabolism; D014779:Virus Replication; D028901:alpha Karyopherins / Q000378:metabolism
chemical_list: D050835:Interferon Regulatory Factors; C446938:VP24 protein, Ebola virus; C080980:VP35 protein, filovirus; D014764:Viral Proteins; D054334:Viral Regulatory and Accessory Proteins; D028901:alpha Karyopherins; D007372:Interferons
references.citation: Immunity. 2005 May;22(5):607-19
references.pmid: 15894278
references.citation: Traffic. 2005 Mar;6(3):205-13
references.pmid: 15702989
references.citation: Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1350-5
references.pmid: 14745017
references.citation: J Biol Chem. 2008 Sep 12;283(37):25660-25670
references.pmid: 18635538
references.citation: J Infect Dis. 2007 Nov 15;196 Suppl 2:S390-9
references.pmid: 17940975
references.citation: Virology. 2005 Oct 25;341(2):179-89
references.pmid: 16095644
references.citation: Biochem Pharmacol. 2006 Nov 30;72(11):1477-84
references.pmid: 16876765
references.citation: Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4825-9
references.pmid: 1350676
references.citation: Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2008-11
references.pmid: 7892216
references.citation: J Virol. 2007 Dec;81(24):13469-77
references.pmid: 17928350
references.citation: J Immunol. 2003 Mar 15;170(6):2797-801
references.pmid: 12626527
references.citation: J Virol. 1999 Apr;73(4):3491-6
references.pmid: 10074208
references.citation: J Virol. 2006 Jun;80(11):5168-78
references.pmid: 16698997
references.citation: Virology. 1995 Jan 10;206(1):116-25
references.pmid: 7831767
references.citation: J Virol. 2005 Dec;79(23):14876-86
references.pmid: 16282487
references.citation: Expert Rev Mol Med. 2004 Sep 21;6(20):1-24
references.pmid: 15383160
references.citation: EMBO J. 1997 Dec 1;16(23):7067-77
references.pmid: 9384585
references.citation: Sci STKE. 2003 Aug 12;2003(195):RE13
references.pmid: 12915721
references.citation: J Virol. 2009 Sep;83(17):8993-7
references.pmid: 19515768
references.citation: Nature. 2008 Apr 3;452(7187):654-8
references.pmid: 18305483
references.citation: J Gen Virol. 2004 Apr;85(Pt 4):983-991
references.pmid: 15039540
references.citation: Nat Rev Genet. 2005 Mar;6(3):206-20
references.pmid: 15703763
references.citation: Virology. 2001 May 25;284(1):20-5
references.pmid: 11352664
references.citation: Trends Immunol. 2004 Sep;25(9):461-4
references.pmid: 15324737
references.citation: Biochem Biophys Res Commun. 1997 May 8;234(1):48-53
references.pmid: 9168958
references.citation: Virology. 1995 Dec 1;214(1):222-8
references.pmid: 8525619
references.citation: Trends Cell Biol. 2004 Sep;14(9):505-14
references.pmid: 15350979
references.citation: J Virol. 2006 Jul;80(13):6430-40
references.pmid: 16775331
references.citation: Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):411-6
references.pmid: 19122151
references.citation: J Virol. 2003 Jul;77(14):7945-56
references.pmid: 12829834
references.citation: Viral Immunol. 2004;17(3):390-400
references.pmid: 15357905
references.citation: J Virol. 2009 Apr;83(7):3069-77
references.pmid: 19153231
references.citation: Virology. 2004 Oct 25;328(2):177-84
references.pmid: 15464838
references.citation: Int J Biochem Cell Biol. 2005 Aug;37(8):1560-6
references.pmid: 15896665
references.citation: J Virol. 2008 Jun;82(11):5348-58
references.pmid: 18353943
references.citation: J Biol Chem. 2003 Jul 25;278(30):28193-200
references.pmid: 12740372
references.citation: Virology. 1998 Dec 20;252(2):324-30
references.pmid: 9878611
references.citation: Cell Signal. 2006 Aug;18(8):1117-26
references.pmid: 16298512
references.citation: Virology. 1998 Dec 5;252(1):179-88
references.pmid: 9875327
references.citation: Lancet. 2003 Dec 13;362(9400):1953-8
references.pmid: 14683653
references.citation: J Virol. 2001 Nov;75(22):11025-33
references.pmid: 11602743
references.citation: J Virol. 2006 Jun;80(11):5156-67
references.pmid: 16698996
references.citation: J Virol. 2006 Mar;80(6):3009-20
references.pmid: 16501110
references.citation: Science. 2006 Nov 10;314(5801):997-1001
references.pmid: 17038589
references.citation: Lab Invest. 2000 Feb;80(2):171-86
references.pmid: 10701687
references.citation: Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6532-6
references.pmid: 7604027
references.citation: Immunol Lett. 2002 Mar 1;80(3):169-79
references.pmid: 11803049
references.citation: Science. 1995 May 19;268(5213):1049-53
references.pmid: 7754385
references.citation: PLoS One. 2008 Apr 30;3(4):e2032
references.pmid: 18446221
references.citation: J Virol. 2003 Jan;77(2):1501-11
references.pmid: 12502864
references.citation: Science. 2007 Nov 30;318(5855):1412-6
references.pmid: 18048681
references.citation: J Virol. 2004 Dec;78(23):12868-76
references.pmid: 15542639
references.citation: Mol Cell Biol. 1999 Nov;19(11):7782-91
references.pmid: 10523667
references.citation: EMBO J. 2002 Apr 2;21(7):1754-63
references.pmid: 11927559
references.citation: J Virol. 2007 Jan;81(1):182-92
references.pmid: 17065211
references.citation: Am J Pathol. 2003 Dec;163(6):2347-70
references.pmid: 14633608
references.citation: Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7633-7
references.pmid: 8052633
references.citation: Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12289-94
references.pmid: 11027311
references.citation: Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):582-7
references.pmid: 9435235
references.citation: Nature. 2006 May 4;441(7089):101-5
references.pmid: 16625202
references.citation: J Cell Biol. 1994 May;125(3):547-55
references.pmid: 8175880
references.citation: PLoS Pathog. 2007 Jun;3(6):e86
references.pmid: 17590081
references.citation: J Infect Dis. 2003 Dec 1;188(11):1630-8
references.pmid: 14639532
references.citation: Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6156-60
references.pmid: 8016130
references.citation: Science. 2006 Nov 10;314(5801):994-7
references.pmid: 17038590
references.citation: J Biol Chem. 1997 Oct 17;272(42):26375-81
references.pmid: 9334211
references.citation: EMBO J. 1996 Apr 15;15(8):1810-7
references.pmid: 8617226
references.citation: Pharmacol Ther. 1998 Apr;78(1):29-46
references.pmid: 9593328
references.citation: Cell. 1986 Apr 25;45(2):195-200
references.pmid: 3698097
references.citation: J Infect Dis. 2003 Dec 1;188(11):1618-29
references.pmid: 14639531
references.citation: J Virol. 1996 Apr;70(4):2208-14
references.pmid: 8642644
references.citation: EMBO J. 1995 Aug 1;14(15):3617-26
references.pmid: 7641681
references.citation: PLoS Pathog. 2009 Jun;5(6):e1000493
references.pmid: 19557165
references.citation: FEBS Lett. 1997 Nov 3;417(1):104-8
references.pmid: 9395085